Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences ADME & Predictive Toxicology Europe

Frank Gonzalez's Biography

Frank Gonzalez, Chief, National Institutes of Health

Frank Gonzalez received a Ph.D. in Oncology from the University of Wisconsin, Madison. Following postdoctoral study, he joined the National Cancer Institute where he is Chief of the Laboratory of Metabolism in the Center for Cancer Research. His research is focused on investigating the drug metabolism, mechanisms of chemical toxicity and carcinogenesis. Metabolomics and mouse models are a major focus of the laboratory.

Frank Gonzalez Image

Metabolomics in Clinical Drug Development

Wednesday, 14 March 2012 at 09:30

Add to Calendar ▼2012-03-14 09:30:002012-03-14 10:30:00Europe/LondonMetabolomics in Clinical Drug DevelopmentADME and Predictive Toxicology Europe in Munich, GermanyMunich,

High throughput metabolomics can be used to identify biomarkers in serum or urine that can stratify populations during clinical trials. This could lead to greater success in drug development by predicting individuals susceptible to adverse drug reactions and drug efficacy.

Add to Calendar ▼2012-03-13 00:00:002012-03-14 00:00:00Europe/LondonADME and Predictive Toxicology EuropeADME and Predictive Toxicology Europe in Munich, GermanyMunich,